South African Test cricketer suspended after positive drugs test
NYSE - LSE
| RIO | -0.42% | 61.98 | $ | |
| CMSC | -1.16% | 22.004 | $ | |
| NGG | 0.22% | 73.58 | $ | |
| RBGPF | 6.25% | 67.2 | $ | |
| SCS | -2.3% | 10.02 | $ | |
| RYCEF | -0.09% | 10.91 | $ | |
| BTI | 0.04% | 44.46 | $ | |
| BCC | -2.96% | 87.335 | $ | |
| VOD | 0.29% | 10.42 | $ | |
| RELX | 0.22% | 55.11 | $ | |
| JRI | -1.02% | 12.69 | $ | |
| CMSD | -1.75% | 21.788 | $ | |
| GSK | 0.34% | 38.53 | $ | |
| BP | -1.09% | 28.885 | $ | |
| AZN | -0.34% | 69.68 | $ | |
| BCE | -0.81% | 21.485 | $ |
South African Test cricketer suspended after positive drugs test
South African cricketer Zubayr Hamza has agreed to a voluntary suspension after testing positive for a prohibited substance, Cricket South Africa announced on Wednesday.
Hamza, 26, has played in six Test matches and one one-day international.
According to a CSA statement, Hamza tested positive for the substance Furosemide following an International Cricket Council anti-doping test on January 17.
Furosemide is a diuretic, prescribed to treat hypertension and reduce swelling caused by fluid build-up in the body. It is on the World Anti-Doping Agency’s banned list because of concerns that it may mask other drugs.
“Zubayr is not disputing the positive test, is cooperating fully with the ICC and has agreed to a voluntary suspension commencing immediately whilst written submissions are presented to the ICC,” said CSA.
“Furosemide is not a performance-enhancing substance and Zubayr has been able to identify how the substance entered his system.”
Hamza was named in the South African squad for a current one-day series against Bangladesh but withdrew before the series started for what CSA described at the time as “personal reasons”.
T.Bianchi--LDdC
